Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual Report

GlaxoSmithKline Pharmaceuticals Annual Report

GlaxoSmithKline Pharmaceuticals submitted its Annual Report for FY2025-26. The report outlines its strategic focus on oncology, specialty medicines, and digital transformation for future growth.

Source

BSE filing, NSE: GLAXO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

GlaxoSmithKline Pharmaceuticals Ltd: key numbers

Share price
₹2,518.90
Market cap
₹42,672 Cr
Revenue (annual)
₹3,822 Cr
Net profit (annual)
₹1,036 Cr
P/E (TTM)
40.0×Sector 46.1×
Promoter holding
75.00%+0.00% QoQ
FII holding
4.75%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from GlaxoSmithKline Pharmaceuticals Ltd

All →

Other annual report announcements

All →